MRNA May 2024 110.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

31.93

-8.07

(-20.17%)

At close: 03:16PM EDT

Loading interactive chart…

Investor's Business Daily
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
The FDA approved Moderna's RSV vaccine, allowing the biotech to launch its second-ever product. But Moderna stock retreated.
Investor's Business Daily
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Moderna stock is on the rise again as investors focus on the potential need for a bird flu vaccine. Is MRNA stock a buy right now?
Investor's Business Daily
The U.S. Is Close To Bankrolling Moderna's Bird Flu Vaccine As Third Dairy Worker Tests Positive
Moderna stock seesawed Thursday after confirming the U.S. government is nearing a deal to fund its pandemic bird flu vaccine.